The Senate Committee on Appropriations on Tuesday released draft legislation proposing $3.21 billion in discretionary funding for the US Food and Drug Administration for FY2021, closely matching the amount the agency would receive under the minibus passed in the House in July.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,